Racial differences in dermatologic conditions associated with HIV: A cross-sectional study of 4679 patients in an urban tertiary care center - 14/04/20
Abstract |
Background |
Because of reduced mortality, patients with HIV are living longer and presenting with chronic diseases. Little is known about racial differences in dermatologic conditions associated with HIV infection.
Objective |
This study examines associated dermatologic conditions in a large population of patients with HIV at a tertiary care center with a diverse patient population.
Methods |
Cross-sectional study of patients with HIV seen between July 14, 2013, and July 14, 2018, in a tertiary health care system. The burden of HIV-related dermatologic conditions was collected by using medical records. Patients with HIV were compared with control individuals of the same race, and significance was assessed using the chi-square test. A Bonferroni correction was performed to control for multiple hypothesis testing.
Results |
The study population (N = 4679) was 64.7% male and 69% African American, with 88.7% of patients receiving antiretroviral therapy. African American patients with HIV had a greater risk of oral hairy leukoplakia (odds ratio [OR], 64.49), herpes zoster (OR, 9.27), prurigo nodularis (OR, 8.80), and squamous cell carcinoma (OR, 5.72).
Limitations |
Our data describe patients seen by 1 health care system.
Conclusions |
African American patients with HIV may be at increased risk for pruritic disorders compared with race-matched control individuals and white patients with HIV.
Le texte complet de cet article est disponible en PDF.Key words : antiretroviral therapy, human immunodeficiency virus, Kaposi sarcoma, oral hairy leukoplakia, prurigo nodularis, pruritus
Abbreviations used : ART, CI, OR
Plan
Funding sources: None. |
|
Disclosure: Dr Kwatra is an advisory board member for Menlo and Trevi Therapeutics and has grant funding from Kiniksa Pharmaceuticals. Dr Sewon Kang is an advisory board member of Almirall, Menlo, Sun Pharma, and Unilever. Drs Bender and Ständer, Ms Tang, and Ms Khanna have no conflicts of interest to declare. |
|
IRB approval status: Waived because only anonymous aggregate-level data counts were used. |
|
Reprints not available from the authors. |
Vol 82 - N° 5
P. 1117-1123 - mai 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?